Semnur Pharmaceuticals, Inc. Payments to Acquire Investments
Semnur Pharmaceuticals, Inc. (SMNR) reported Payments to Acquire Investments of $825.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-04-02.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2025-04-02
- Semnur Pharmaceuticals, Inc. payments to acquire investments for the quarter ending 2023-12-31 was $0.00.
- Semnur Pharmaceuticals, Inc. payments to acquire investments for the quarter ending 2023-09-30 was $0.00.
- Semnur Pharmaceuticals, Inc. payments to acquire investments for the quarter ending 2022-12-31 was $0.00.
- Semnur Pharmaceuticals, Inc. payments to acquire investments for fiscal 2023 was $825.00K, a 99.02% decline from fiscal 2022.
- Semnur Pharmaceuticals, Inc. payments to acquire investments for fiscal 2022 was $84.15M.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-02 | $0.00 derived: sum of 2 quarters · filed 2025-04-02 | $825.00K 10-K · filed 2025-04-02 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | $825.00K 10-Q · filed 2024-11-19 | ||
| 2023-06-30 | $825.00K 10-Q · filed 2024-08-19 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $84.15M 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $84.15M 10-Q · filed 2023-11-09 |